Purchases and Sales Made in Q3 2021 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q3 2021. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-911K- 94.89% |
$68.1M - $77.9M
|
49.1K
$3.27M
|
|
|
Nov 15, 2021
Q3 2021
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-954K- 46.75% |
$71.4M - $81.6M
|
1.09M
$72.4M
|
|
|
Nov 05, 2021
Q3 2021
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-2.17MClosed |
$162M - $185M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Capital Research Global Investors
Los Angeles, CA |
SELL
|
- |
-4.44M- 20.11% |
$332M - $380M
|
17.6M
$1.18B
|